» Articles » PMID: 18034877

Missed Opportunities for Participation in Prevention of Mother to Child Transmission Programmes: Simplicity of Nevirapine Does Not Necessarily Lead to Optimal Uptake, a Qualitative Study

Overview
Journal AIDS Res Ther
Publisher Biomed Central
Date 2007 Nov 24
PMID 18034877
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The objective of this study was to examine missed opportunities for participation in a prevention of mother-to-child transmission (PMTCT) programme in three sites in South Africa. A rapid anthropological assessment was used to collect in-depth data from 58 HIV-positive women who were enrolled in a larger cohort study to assess mother-to-child HIV transmission. Semi-structured interviews were conducted with the women in order to gain an understanding of their experiences of antenatal care and to identify missed opportunities for participation in PMTCT.

Results: 15 women actually missed their nevirapine not because of stigma and ignorance but because of health systems failures. Six were not tested for HIV during antenatal care. Two were tested but did not receive their results. Seven were tested and received their results, but did not receive nevirapine. Health Systems failure for these programme leakages ranged from non-availability of counselors, supplies such as HIV test kits, consent forms, health staff giving the women incorrect instructions about when to take the tablet and health staff not supplying the women with the tablet to take.

Conclusion: HIV testing enables access to PMTCT interventions and should therefore be strengthened. The single dose nevirapine regimen is simple to implement but the all or nothing nature of the regimen may result in many missed opportunities. A short course dual or triple drug regimen could increase the effectiveness of PMTCT programmes.

Citing Articles

Prevention of mother-to-child transmission of hepatitis B virus in antenatal care and maternity services, Mozambique.

Loarec A, Nguyen A, Molfino L, Chissano M, Madeira N, Rusch B Bull World Health Organ. 2022; 100(1):60-69.

PMID: 35017758 PMC: 8722623. DOI: 10.2471/BLT.20.281311.


Strategies to integrate community-based traditional and complementary healthcare systems into mainstream HIV prevention programs in resource-limited settings.

Thapa S, Aro A Global Health. 2018; 14(1):64.

PMID: 29973230 PMC: 6032556. DOI: 10.1186/s12992-018-0383-4.


The lived experiences of rural women diagnosed with the human immunodeficiency virus in the antenatal period.

Fords G, Crowley T, van der Merwe A SAHARA J. 2017; 14(1):85-92.

PMID: 28949277 PMC: 5639609. DOI: 10.1080/17290376.2017.1379430.


Implementation and Operational Research: Effects of Antenatal Care and HIV Treatment Integration on Elements of the PMTCT Cascade: Results From the SHAIP Cluster-Randomized Controlled Trial in Kenya.

Turan J, Onono M, Steinfeld R, Shade S, Owuor K, Washington S J Acquir Immune Defic Syndr. 2015; 69(5):e172-81.

PMID: 25967269 PMC: 4501892. DOI: 10.1097/QAI.0000000000000678.


A systematic review of missed opportunities for improving tuberculosis and HIV/AIDS control in Sub-saharan Africa: what is still missed by health experts?.

Keugoung B, Fouelifack F, Fotsing R, Macq J, Meli J, Criel B Pan Afr Med J. 2014; 18:320.

PMID: 25478041 PMC: 4250026. DOI: 10.11604/pamj.2014.18.320.4066.


References
1.
Cartoux M, Meda N, van de Perre P, Newell M, de Vincenzi I, Dabis F . Acceptability of voluntary HIV testing by pregnant women in developing countries: an international survey. Ghent International Working Group on Mother-to-Child Transmission of HIV. AIDS. 1999; 12(18):2489-93. PMC: 4710789. DOI: 10.1097/00002030-199818000-00019. View

2.
Fernandez M, Wilson T, Ethier K, Walter E, Gay C, Moore J . Acceptance of HIV testing during prenatal care. Perinatal Guidelines Evaluation Project. Public Health Rep. 2001; 115(5):460-8. PMC: 1308602. DOI: 10.1093/phr/115.5.460. View

3.
Frieden T, Das-Douglas M, Kellerman S, Henning K . Applying public health principles to the HIV epidemic. N Engl J Med. 2005; 353(22):2397-402. DOI: 10.1056/NEJMsb053133. View

4.
Walmsley S . Opt in or opt out: what is optimal for prenatal screening for HIV infection?. CMAJ. 2003; 168(6):707-8. PMC: 154916. View

5.
Doherty T, McCoy D, Donohue S . Health system constraints to optimal coverage of the prevention of mother-to-child HIV transmission programme in South Africa: lessons from the implementation of the national pilot programme. Afr Health Sci. 2005; 5(3):213-8. PMC: 1831931. DOI: 10.5555/afhs.2005.5.3.213. View